DNAlytics
Curated by SignalProvider of data-driven personalized medicine from R&D to market access
Overview
DNAlytics is a UCLouvain spin-off that bases its activities on a data mining technology platform. Based on this technology platform, DNAlytics covers the whole development of data-driven personalized medicine solutions, from R&D to market access. DNAlytics business model spans two offerings: a data mining consultancy service (prognosis, diagnosis, theranosis, patient stratification and clinical trial support) and the development of a data-driven personalized medicine product pipeline (rheumatology and oncology). Their first marketed product is RheumaKit, a solution for the differential diagnosis of patients with Undifferentiated Arthritis. The solution is CE-marked for differential diagnostic application, while theranostic applications are in development. It also develops and/or maintains the following software-REED - Rapid and Easy Evaluation of Datasets, LiblineaR - a software library for very large data sets classification and regression, jForest - a general framework for Machine Learning implementing tree ensemble based classification methods, and BLISS - Biomarker List Interpretation Simple Software.
Key facts
- Founded
- 2012
- Headquarters
- Louvain la Neuve, Belgium
- Stage
- Sign up to view
- Industry
- Health Technology
Contact
- Primary office
- Sign up to view
- Phone
- Sign up to view